Summary: Pycnodysostosis is a rare sclerosing bone dystrophy. The main clinical features are short stature and oral and maxillofacial abnormalities such as a large head, a small and underdeveloped face with prominent nose and eyes, irregular dentition, small hands and feet with dystrophic nails, and trunk deformities such as scoliosis. The differential diagnosis is established with other skeletal dysplasias such as osteopetrosis, cleidocranial dysplasia, and idiopathic acroosteolysis. Since its first description in 1962 by Maroteaux and Lamy, about 100 cases have been published, some of these with uncommon features. We describe the case of a 22-year-old European man with pycnodysostosis who developed a chondroblastic osteosarcoma of the right femur. No case of bone cancer in this sclerosing bone disease had been described so far.
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Key Words: pediatric oncology, pycnodysostosis, oteosarcoma (J Pediatr Hematol Oncol 2012;34:545-547) P ycnodysostosis meaning "thick defective bones" (from the Greek pycnos = dense, dys = defective, and stosis = of bone) is a rare sclerosing bone dystrophy. It was first described in 1962 by Maroteaux and Lamy as a variant of osteopetrosis (Albers-Scho¨nberg disease). 1 It is an autosomal recessive disorder, the main clinical features of which are short stature at all ages, large head with frontal and parietal bossing, delayed closure of the fontanelles with wide, unossified cranial sutures, a small and underdeveloped face, with a beaked nose, prominent eyes, obtuse mandibular angle, a high grooved palate, and irregular dentition. Hands and feet are short, broad, with short terminal phalanges and dystrophic lenticulate nails. The acromial end of the clavicles is hypoplastic,s and trunk deformities such as scoliosis, increased lumbar lordosis, or kyphosis can be seen. [2] [3] [4] Usually diagnosed at an early age, the diagnosis is sometimes late, made because of bone fracture due to severe bone fragility resulting from increased bone density. 5 The differential diagnosis is to be made with other skeletal dysplasias such as osteopetrosis, cleidocranial dysplasia, and idiopathic acro-osteolysis.
No case of bone cancer in this sclerosing bone disease has been described so far. We report the first case of chondroblastic osteosarcoma (OS) in a patient with pycnodysostosis.
CASE REPORT
We present the case of a young man diagnosed with pycnodysostosis during his first year of life. Born to consanguineous parents and adopted at the age of 3 months, he showed the main clinical features as presented before, such as short stature, a large head with a small and underdeveloped face, and small hands and feet with dystrophic nails (Fig. 1) . He also had a cleft palate (usually not described in pycnodysostosis). Diagnosis was based on radiographs that showed typical signs of pycnodysostosis (Fig. 2) .
This young man was referred to our department with a 7-month history of pain in his upper right leg. One month before diagnosis he started to limp and a swelling appeared. X-ray showed a large heavily calcified mass on the upper part of his right femur; magnetic resonance imaging scan showed a large tumor on the right diaphysis of the femur (Fig. 3) . Biopsy of the lesion confirmed the diagnosis of chondroblastic OS (Fig. 4) . No metastasis was found.
He was treated according to the French protocol osteosarcoma 2006. Surgery consists of resection-reconstruction of the bone. He has been in first complete remission since >2 years after the end of treatment.
DISCUSSION
Pycnodysostosis, an inherited autosomal recessive disorder, is due to a genetic defect located on chromosome 1q21. Different mutations 6,7 located on this chromosome are responsible for changes in a lysosomal cysteine protease, cathepsin K. This protease, expressed in osteoclasts, is a key enzyme in the degradation of bone matrix proteins. Because of the reduced expression of cathepsin K in the osteoclasts, these cells are not able to remove the organic matrix (95% of which is collagen type 1). This osteoclastic dysfunction results in reduced bone resorption. Bone resorption in pycnodysostosis is defective but not completely inhibited, as there is a nonosteoclastic pathway for degradation of bone matrix.
Other bone-lining cells containing matrix metalloproteinase activities are able to degrade demineralized collagen left over from osteoclasts. 8, 9 However, the collagen breakdown products resulting from cathepsin K activity are different from those resulting from the alternative proteinases, which suggests that the microenvironment of bone is altered. 10 Furthermore, osteoblastic function and bone formation seem to be altered as bone formation and bone resorption are closely linked and the dysfunction of one can imbalance the other. The abnormal bone turnover due to cathepsin K deficiency in patients with pycnodysostosis results in osteosclerosis and a highly disturbed bone architecture that cannot adapt to mechanical stress. This leads to a highly disordered lamellar structure and therefore an increased susceptibility to fractures. 11 Fractures are
